These results give rise to a hypothesis that could be tested in future studies, namely that chromosomal copy number alterations rather than point mutations account for activation of the RAS-signalling pathway in combination with loss of the CDKN2A-TP53 tumour suppressor pathways to drive UPS tumour formation in non-Asian individuals. Here, CDKN2A is linked to neoplasm.